Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04914741
Title A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) (COALITION)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + RO7082859 + Vincristine Sulfate

Cyclophosphamide + Doxorubicin + Polatuzumab vedotin-piiq + Prednisolone + Rituximab + RO7082859

Age Groups: adult | senior
Covered Countries


No variant requirements are available.